| Year |
Citation |
Score |
| 2023 |
Crotty EE, Wilson AL, Davidson T, Tahiri S, Gust J, Griesinger AM, Venkataraman S, Park JR, Mueller S, Rood BR, Hwang EI, Wang LD, Vitanza NA. Cellular Therapy for Children with Central Nervous System Tumors: Mining and Mapping the Correlative Data. Current Oncology Reports. PMID 37160547 DOI: 10.1007/s11912-023-01423-3 |
0.304 |
|
| 2022 |
Gust J, Rawlings-Rhea SD, Wilson AL, Tulberg NM, Sherman AL, Seidel KD, Wu QV, Park JR, Gardner RA, Annesley CE. GFAP and NfL increase during neurotoxicity from high baseline levels in pediatric CD19-CAR T-cell patients. Blood Advances. PMID 36006611 DOI: 10.1182/bloodadvances.2022008119 |
0.339 |
|
| 2022 |
Faulhaber LD, D'Costa O, Shih AY, Gust J. Antibody-based leukocyte label for two-photon brain imaging in mice. Neurophotonics. 9: 031917. PMID 35637871 DOI: 10.1117/1.NPh.9.3.031917 |
0.603 |
|
| 2022 |
Crotty E, Gust J. Pediatric ependymoma: New perspectives on older trials. Neuro-Oncology. PMID 35325202 DOI: 10.1093/neuonc/noac060 |
0.188 |
|
| 2022 |
Shalabi H, Nellan A, Shah NN, Gust J. Immunotherapy Associated Neurotoxicity in Pediatric Oncology. Frontiers in Oncology. 12: 836452. PMID 35265526 DOI: 10.3389/fonc.2022.836452 |
0.35 |
|
| 2021 |
Faulhaber LD, Phuong AQ, Hartsuyker KJ, Cho Y, Mand KK, Harper SD, Olson AK, Garden GA, Shih AY, Gust J. Brain capillary obstruction during neurotoxicity in a mouse model of anti-CD19 chimeric antigen receptor T-cell therapy. Brain Communications. 4: fcab309. PMID 35169706 DOI: 10.1093/braincomms/fcab309 |
0.627 |
|
| 2021 |
Vitanza NA, Johnson AJ, Wilson AL, Brown C, Yokoyama JK, Künkele A, Chang CA, Rawlings-Rhea S, Huang W, Seidel K, Albert CM, Pinto N, Gust J, Finn LS, Ojemann JG, et al. Locoregional infusion of HER2-specific CAR T cells in children and young adults with recurrent or refractory CNS tumors: an interim analysis. Nature Medicine. PMID 34253928 DOI: 10.1038/s41591-021-01404-8 |
0.414 |
|
| 2021 |
Paczesny S, Pasquini MC, Pavletic SZ, Agarwal A, Spellman S, Kean L, Bernatchez C, Gust J, Staedtke V, Perales MA. Blueprint for the discovery of biomarkers of toxicity and efficacy for CAR T cells and T-cell engagers. Blood Advances. 5: 2519-2522. PMID 34100901 DOI: 10.1182/bloodadvances.2021004604 |
0.403 |
|
| 2021 |
Shalabi H, Gust J, Taraseviciute A, Wolters PL, Leahy AB, Sandi C, Laetsch TW, Wiener L, Gardner RA, Nussenblatt V, Hill JA, Curran KJ, Olson TS, Annesley C, Wang HW, et al. Beyond the storm - subacute toxicities and late effects in children receiving CAR T cells. Nature Reviews. Clinical Oncology. PMID 33495553 DOI: 10.1038/s41571-020-00456-y |
0.432 |
|
| 2020 |
Gust J, Ponce R, Liles WC, Garden GA, Turtle CJ. Cytokines in CAR T Cell-Associated Neurotoxicity. Frontiers in Immunology. 11: 577027. PMID 33391257 DOI: 10.3389/fimmu.2020.577027 |
0.36 |
|
| 2020 |
Malbari F, Partap S, Gust J, Duke E, Sato A, Khakoo Y, Ullrich NJ. Neuro-Oncology Training for the Child Neurology Resident. Journal of Child Neurology. 883073820955101. PMID 32907446 DOI: 10.1177/0883073820955101 |
0.335 |
|
| 2019 |
Ravanpay AC, Gust J, Johnson AJ, Rolczynski LS, Cecchini M, Chang CA, Hoglund VJ, Mukherjee R, Vitanza NA, Orentas RJ, Jensen MC. EGFR806-CAR T cells selectively target a tumor-restricted EGFR epitope in glioblastoma. Oncotarget. 10: 7080-7095. PMID 31903167 DOI: 10.18632/Oncotarget.27389 |
0.472 |
|
| 2019 |
Gust J, Annesley CE, Gardner RA, Bozarth X. EEG Correlates of Delirium in Children and Young Adults With CD19-Directed CAR T Cell Treatment-Related Neurotoxicity. Journal of Clinical Neurophysiology : Official Publication of the American Electroencephalographic Society. PMID 31851018 DOI: 10.1097/Wnp.0000000000000669 |
0.499 |
|
| 2019 |
Gardner R, Ceppi F, Rivers J, Annesley C, Summers C, Taraseviciute A, Gust J, Leger KJ, Tarlock K, Cooper T, Finney OC, Brakke H, Li DH, Park JR, Jensen MC. Preemptive Mitigation of CD19 CAR T Cell Cytokine Release Syndrome Without Attenuation of Anti-Leukemic Efficacy. Blood. PMID 31697826 DOI: 10.1182/Blood.2019001463 |
0.525 |
|
| 2019 |
Gust J, Ishak GE. Chimeric Antigen Receptor T-Cell Neurotoxicity Neuroimaging: More Than Meets the Eye. American Journal of Neuroradiology. 40. PMID 31488503 DOI: 10.3174/Ajnr.A6184 |
0.519 |
|
| 2019 |
Gust J, Finney OC, Li D, Brakke HM, Hicks RM, Futrell RB, Gamble DN, Rawlings-Rhea SD, Khalatbari HK, Ishak GE, Duncan VE, Hevner RF, Jensen MC, Park JR, Gardner RA. Glial injury in neurotoxicity after pediatric CD19-directed CAR-T cell therapy. Annals of Neurology. PMID 31074527 DOI: 10.1002/Ana.25502 |
0.522 |
|
| 2019 |
Vitanza N, Johnson A, Beebe A, Gust J, Hauptman J, Hoeppner C, Wilson A, Perez F, Pinto N, Orenta R, Finn L, Gardner R, Park J, Jensen M. IMMU-02. LOCOREGIONAL HER2CAR T CELLS FOR PEDIATRIC CENTRAL NERVOUS SYSTEM TUMORS: PRECLINICAL EFFICACY TO TOLERABILITY IN FIRST PATIENT Neuro-Oncology. 21: ii93-ii93. DOI: 10.1093/Neuonc/Noz036.123 |
0.451 |
|
| 2018 |
Gust J, Taraseviciute A, Turtle CJ. Neurotoxicity Associated with CD19-Targeted CAR-T Cell Therapies. Cns Drugs. PMID 30387077 DOI: 10.1007/S40263-018-0582-9 |
0.581 |
|
| 2018 |
Piacitelli AM, Jensen DM, Brandling-Bennett H, Gray MM, Batra M, Gust J, Thaker A, Paschal C, Tsuchiya K, Pritchard CC, Perkins J, Mirzaa GM, Bennett JT. Characterization of a severe case of PIK3CA-related overgrowth at autopsy by droplet digital polymerase chain reaction and report of PIK3CA sequencing in 22 patients. American Journal of Medical Genetics. Part A. PMID 30063105 DOI: 10.1002/Ajmg.A.40487 |
0.357 |
|
| 2018 |
Vitanza N, Gust J, Leary S, Pinto N, Lee A, Hauptman J, Ojemann J, Elliott L, Finney O, Lindgren C, Hossain Z, Pierce R, Lieberman N, Crane C, Johnson A, et al. IMMU-11. BRAINCHILD PIPELINE: LOCOREGIONAL IMMUNOTHERAPY WITH CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELLS FOR RECURRENT/REFRACTORY CENTRAL NERVOUS SYSTEM TUMORS Neuro-Oncology. 20: i100-i101. DOI: 10.1093/Neuonc/Noy059.327 |
0.494 |
|
| 2017 |
Natarajan N, Beatty CW, Gust J, Hamiwka L. Provider Practices of Phenobarbital Discontinuation in Neonatal Seizures. Journal of Child Neurology. 883073817745990. PMID 29256315 DOI: 10.1177/0883073817745990 |
0.326 |
|
| 2017 |
Gust J, Hay KA, Hanafi LA, Li D, Myerson D, Gonzalez-Cuyar LF, Yeung C, Liles WC, Wurfel M, Lopez JA, Chen J, Chung D, Harju-Baker S, Özpolat T, Fink KR, et al. Endothelial Activation and Blood-Brain Barrier Disruption in Neurotoxicity after Adoptive Immunotherapy with CD19 CAR-T Cells. Cancer Discovery. PMID 29025771 DOI: 10.1158/2159-8290.Cd-17-0698 |
0.568 |
|
| 2017 |
Hay KA, Hanafi LA, Li D, Gust J, Liles WC, Wurfel MM, López JA, Chen J, Chung D, Harju-Baker S, Cherian S, Chen X, Riddell SR, Maloney DG, Turtle CJ. Kinetics and Biomarkers of Severe Cytokine Release Syndrome after CD19 Chimeric Antigen Receptor-modified T Cell Therapy. Blood. PMID 28924019 DOI: 10.1182/blood-2017-06-793141 |
0.461 |
|
| 2017 |
Turtle CJ, Hay KA, Gust J, Hanafi L, Li D, Liles WC, Wurfel M, Harju-Baker S, Myerson D, Gonzalez-Cuyar L, Yeung CC, Riddell SR, Maloney DG. Cytokine release syndrome (CRS) and neurotoxicity (NT) after CD19-specific chimeric antigen receptor- (CAR-) modified T cells. Journal of Clinical Oncology. 35: 3020-3020. DOI: 10.1200/JCO.2017.35.15_suppl.3020 |
0.482 |
|
| 2017 |
Turtle CJ, Hay KA, Hanafi L, Gust J, Liles WC, López JA, Chen J, Chung DW, Wurfel MM, Harju-Baker S, Ozpolat H, Li D, Myerson D, Gonzalez-Cuyar LF, Yeung C, et al. Endothelial Activation and Blood-Brain Barrier Disruption in Neurotoxicity after CD19 CAR-T Cell Immunotherapy Blood. 130: 805-805. DOI: 10.1182/Blood.V130.Suppl_1.805.805 |
0.555 |
|
| 2016 |
Gardner R, Leger KJ, Annesley CE, Summers C, Rivers J, Gust J, Tarlock K, Cooper TM, Pinto NR, Finney O, Smithers H, Oron A, Li D, Park JR, Jensen MC. Decreased Rates of Severe CRS Seen with Early Intervention Strategies for CD19 CAR-T Cell Toxicity Management Blood. 128: 586-586. DOI: 10.1182/blood.V128.22.586.586 |
0.41 |
|
| 2011 |
Gust J, Reh TA. Adult donor rod photoreceptors integrate into the mature mouse retina. Investigative Ophthalmology & Visual Science. 52: 5266-72. PMID 21436277 DOI: 10.1167/Iovs.10-6329 |
0.569 |
|
| 2010 |
Reh TA, Lamba D, Gust J. Directing human embryonic stem cells to a retinal fate. Methods in Molecular Biology (Clifton, N.J.). 636: 139-53. PMID 20336521 DOI: 10.1007/978-1-60761-691-7_9 |
0.529 |
|
| 2009 |
Lamba DA, Gust J, Reh TA. Transplantation of human embryonic stem cell-derived photoreceptors restores some visual function in Crx-deficient mice. Cell Stem Cell. 4: 73-9. PMID 19128794 DOI: 10.1016/J.Stem.2008.10.015 |
0.58 |
|
| 2006 |
Hunt PN, Gust J, McCabe AK, Bosma MM. Primary role of the serotonergic midline system in synchronized spontaneous activity during development of the embryonic mouse hindbrain. Journal of Neurobiology. 66: 1239-52. PMID 16902991 DOI: 10.1002/neu.20259 |
0.527 |
|
| 2006 |
Hunt PN, McCabe AK, Gust J, Bosma MM. Spatial restriction of spontaneous activity towards the rostral primary initiating zone during development of the embryonic mouse hindbrain. Journal of Neurobiology. 66: 1225-38. PMID 16902989 DOI: 10.1002/neu.20260 |
0.521 |
|
| 2003 |
Gust J, Wright JJ, Pratt EB, Bosma MM. Development of synchronized activity of cranial motor neurons in the segmented embryonic mouse hindbrain. The Journal of Physiology. 550: 123-33. PMID 12730346 DOI: 10.1113/jphysiol.2002.038737 |
0.506 |
|
| Show low-probability matches. |